Physician

Brian A Costell, M.D.

According to 2025 Medicare claims, Brian Costell, M.D. (NPI: 1174563688) practices epileptologists in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is NEUROSCIENCE CONSULTANTS LLP (NPI: 1346217452; TIN: 542107535) and primary practice location at 33428-2236.

Costell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,110 traditional Medicare patients, billed 1,700,970 HCPCS/CPT codes, and received $3,812,211 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 5,479 prescription claims across 933 beneficiaries totaling $2,145,510 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). DME data shows 38 claims. Open Payments data shows 439 records totaling $797,325. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $320,350 to $3,812,211. Similarly, Part D prescription costs have risen steadily, from $1,980,667 to $2,145,510. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,487 and ending at $5,668.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	746	20,976	$320,350
2016	709	27,368	$279,851
2017	737	39,481	$389,562
2018	707	63,029	$810,307
2019	830	59,703	$1,009,766
2020	867	52,413	$1,154,232
2021	981	61,634	$1,665,790
2022	814	73,273	$1,750,915
2023	807	186,330	$2,011,172
2024	1,110	1,700,970	$3,812,211

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	669	7,511	$1,980,667
2016	657	6,401	$1,869,882
2017	720	6,393	$1,894,124
2018	713	6,405	$1,919,248
2019	878	6,739	$2,175,710
2020	895	5,024	$2,477,013
2021	944	5,148	$2,036,094
2022	1,076	6,192	$2,621,415
2023	1,070	6,731	$2,984,216
2024	933	5,479	$2,145,510

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	11	105	$6,762
2020	N/R	22	$1,169
2021	N/R	19	$1,250
2022	N/R	N/R	N/R
2023	N/R	11	$1,036
2024	N/R	38	$3,624

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	244	353	$134
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	201	201	$128
96413	Administration of chemotherapy into vein, 1 hour or less	228	2,231	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	481	876	$95
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	400	692	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	57	1,519	$414,948
Gammaked	Immune Globul G/Gly/Iga Avg 46	16	336	$183,710
Ingrezza	Valbenazine Tosylate	12	360	$105,254
Nurtec Odt	Rimegepant Sulfate	72	2,115	$99,394
Copaxone	Glatiramer Acetate	15	420	$84,681

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1805	Dynamic adjustable wrist extension / flexion device, includes soft interface material	Y	N/R	26	$2,399
E1800	Dynamic adjustable elbow extension/flexion device, includes soft interface material	Y	N/R	12	$1,225

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	372	$65,665	Eisai Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	67	$731,660	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian A. Costell, M.D.?

Tedicare shows public-source Medicare data for Brian A. Costell, M.D. (NPI 1174563688), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian A. Costell, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian A. Costell, M.D.?

Brian A. Costell, M.D. is linked to NEUROSCIENCE CONSULTANTS LLP (billing NPI 1346217452) in the available physician profile data.

Does Brian A. Costell, M.D. have Open Payments data?

Brian A. Costell, M.D. has 439 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.